Metraipolis › archive › dc_f78aba10907e

Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors - a retrospective single center analysis — Europe PMC PMID:41174705

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41174705
DOI
10.1186/s12885-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-08T21:02:42.742Z
SHA-256 of the archived text
99102a61cb1b3f243d891e4c33a3a05c4e4e1d33ba7f8b69bb1adaefab0ce59f
Stable URL of this page
https://metraipolis.com/documento/dc_f78aba10907e

How to cite

Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors - a retrospective single center analysis — Europe PMC PMID:41174705 — Europe PMC (en), https://europepmc.org/article/MED/41174705 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f78aba10907e (Metraipolis archive dc_f78aba10907e, sha256 99102a61cb1b3f243d891e4c33a3a05c4e4e1d33ba7f8b69bb1adaefab0ce59f)
BibTeX
@misc{dcf78aba10907e,
  title = {Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors - a retrospective single center analysis — Europe PMC PMID:41174705},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41174705},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f78aba10907e; sha256 99102a61cb1b3f243d891e4c33a3a05c4e4e1d33ba7f8b69bb1adaefab0ce59f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41174705. Agents can read the archived copy with the MCP tool read_document.